HeartSciences (HSCS) Stock Forecast: StockMap's 2-Week Call

HSCS stock forecast: StockMap's model leans Underperform on HeartSciences for the two weeks after the Nov 13 close, toward HSCS trailing the growth index. It is a lean inside the no-call band, not a call, and not a price target. Right in 2 of 6 two-week windows on HSCS since Aug 21; by chance, a call on the same dates was right 62% of the time.

HeartSciences last closed at $2.12, -6.19% on the session.

Against the IVW growth benchmark the position is -5.28% over the forecast window.

HeartSciences' market cap is $10.53M as of November 13, 2026.

Leans down ↘: a small lean, not a call · the next 2 weeks, vs S&P 500 growth. The lean on a scale from −100 to +100 is -45 (too close to call).

Where HSCS sits: sized by market cap, coloured by the day's move.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

39 daily calls for HSCS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks HeartSciences in the 1st percentile on return on equity, where 100 is best.

HeartSciences is classified under Health Care / Health Care Equipment & Supplies.

StockMap tracks HeartSciences as the 130th largest of the 142 companies it covers in the Health Care Equipment & Supplies industry, part of the Health Care sector.

Across that group the current two-week reads are 74 Neutral, 52 Moderate Underperform, 13 Strong Underperform and 3 Moderate Outperform.

On that composite HeartSciences ranks 123rd of 142 in the group, against a group median of -0.15.

Other Health Care stocks

Research and education, not investment advice. The calls on this page come from StockMap's automated model, run on the close of November 13, 2026, and are the same for every reader. Calls are graded in public, misses included: how calls are graded, and the record. Who makes the calls and who pays for the site: Disclosures.

HeartSciences (HSCS) — StockMap 2-week forecast & tracked accuracy